Neoadjuvant Chemotherapy Clinical Trials
8 recruitingDrug
Phase 25Phase 31Not Applicable1
Showing 1–8 of 8 trials
Recruiting
Phase 2
Partial Cystectomy & Extended Pelvic Lymph Node Dissection With SOC Perioperative Systemic Therapy
Malignant Neoplasm of Bladder
Case Comprehensive Cancer Center40 enrolled1 locationNCT06290687
Recruiting
Phase 2
Neoadjuvant Therapy Combined With Trastuzumab Rezetecan and Toripalimab for HR+/HER2-low Breast Cancer (NEOTORCH-BREAST 08)
HR Positive/HER2 Low Breast Cancer
First Affiliated Hospital of Zhejiang University111 enrolled5 locationsNCT07383818
Recruiting
Not Applicable
Effect of Neoadjuvant Chemotherapy on MRI Accuracy Before Cystectomy
Muscle Invasive Bladder Cancer
Assiut University76 enrolled2 locationsNCT07202819
Recruiting
Phase 2
Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer
Breast Cancer
Xijing Hospital27 enrolled2 locationsNCT06914440
Recruiting
Phase 3
Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer : a Randomized, Open-label, Parallel-controlled, Multi-center Phase III Study (NEOTORCH-BREAST04)
HR+/HER2- Breast Cancer
First Affiliated Hospital of Zhejiang University194 enrolled13 locationsNCT06977893
Recruiting
Phase 2
Iparomlimab and Tuvonralimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy for CC
Cervical Cancers
Obstetrics & Gynecology Hospital of Fudan University35 enrolled1 locationNCT06878222
Recruiting
AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy
Gastric CancerImagePathology
Chinese Academy of Sciences200 enrolled22 locationsNCT06035250
Recruiting
Phase 2
Watch and Wait for NeoAdjuvant Concurrent Radiochemotherapy Combined With Camrelizumab in Patients With Resectable ESCC
Esophageal Squamous Cell Carcinoma
Zhejiang Cancer Hospital100 enrolled3 locationsNCT05507411